{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T05:24:44Z","timestamp":1741238684939,"version":"3.38.0"},"reference-count":40,"publisher":"JLE","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Dermatol"],"published-print":{"date-parts":[[2018,1,1]]},"DOI":"10.1684\/ejd.2017.3183","type":"journal-article","created":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T15:11:44Z","timestamp":1696864304000},"page":"44-49","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Incidence and ten-year follow-up of primary cutaneous lymphomas: a single-centre cohort study"],"prefix":"10.1684","volume":"28","author":[{"given":"Martina","family":"Maurelli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianpaolo","family":"Tessari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Colato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donatella","family":"Schena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giampiero","family":"Girolomoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"18929","published-online":{"date-parts":[[2018,4,3]]},"reference":[{"key":"3183_CR1","doi-asserted-by":"publisher","first-page":"v177","DOI":"10.1093\/annonc\/mdq183","volume":"21","author":"R. Willemze","year":"2010","unstructured":"Willemze R, Dreyling M. Primary cutaneous lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2010; 21: v177\u201380.","journal-title":"Ann Oncol"},{"key":"3183_CR2","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.det.2015.06.001","volume":"33","author":"E.A. Olsen","year":"2015","unstructured":"Olsen EA. Evaluation, diagnosis, and staging of cutaneous lymphoma. Dermatol Clin 2015; 33: 643\u201354.","journal-title":"Dermatol Clin"},{"key":"3183_CR3","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.clml.2012.06.010","volume":"12","author":"L.D. Wilson","year":"2012","unstructured":"Wilson LD, Hinds GA, Yu JB. Age, race, gender, stage and the incidence of cutaneous lymphoma. Clin Lymphoma Myeloma Leuk 2012; 12: 291\u20136.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"3183_CR4","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","volume":"12","author":"S.H. Swerdlow","year":"2016","unstructured":"Swerdlow SH, Campo E, Pileri SA, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 2016; 12: 2375\u201390.","journal-title":"Blood"},{"key":"3183_CR5","doi-asserted-by":"publisher","first-page":"5064","DOI":"10.1182\/blood-2008-10-184168","volume":"113","author":"P.T. Bradford","year":"2009","unstructured":"Bradford PT, Devesa SS, Anderson WF, Toro JR. Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases. Blood 2009; 113: 5064\u201373.","journal-title":"Blood"},{"key":"3183_CR6","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1002\/ajh.23756","volume":"89","author":"R.A. Wilcox","year":"2014","unstructured":"Wilcox RA. Cutaneous T-cell lymphoma: 2014 update on diagnosis, risk-stratification, and management. Am J Hematol 2014; 89: 837\u201351.","journal-title":"Am J Hematol"},{"key":"3183_CR7","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1001\/archderm.143.7.854","volume":"143","author":"V.D. Criscione","year":"2007","unstructured":"Criscione VD, Weinstock MA. Incidence of cutaneous T-cell lymphoma in the United States, 1973-2002. Arch Dermatol 2007; 143: 854\u20139.","journal-title":"Arch Dermatol"},{"key":"3183_CR8","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.det.2015.05.003","volume":"33","author":"L.C. Pinter-Brown","year":"2015","unstructured":"Pinter-Brown LC. Diagnosis and management of cutaneous B-cell lymphoma. Dermatol Clin 2015; 33: 835\u201340.","journal-title":"Dermatol Clin"},{"key":"3183_CR9","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1111\/j.1346-8138.2010.01049.x","volume":"38","author":"A. Fujita","year":"2011","unstructured":"Fujita A, Hamada T, Iwatsuki K. Retrospective analysis of 133 patients with cutaneous lymphomas from a single Japanese medical centre between 1995 and 2008. J Dermatol 2011; 38: 524\u201330.","journal-title":"J Dermatol"},{"key":"3183_CR10","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1111\/j.1365-2230.2012.04461.x","volume":"38","author":"J.H. Lee","year":"2013","unstructured":"Lee JH, Yoo DS, Kang H, et al. Characteristics of primary cutaneous lymphoma according to WHO-EORTC classification in Korea. Clin Exp Dermatol 2013; 38: 457\u201363.","journal-title":"Clin Exp Dermatol"},{"key":"3183_CR11","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1111\/jdv.12907","volume":"29","author":"J. Eder","year":"2015","unstructured":"Eder J, Kern A, Moser J, Kitzw\u00f6gerer M, Sedivy R, Trautinger F. Frequency of primary cutaneous lymphoma variants in Austria: retrospective data from a dermatology referral centre between 2006 and 2013. J Eur Acad Dermatol Venereol 2015; 29: 1517\u201323.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"3183_CR12","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1111\/j.1365-2133.2007.08239.x","volume":"157","author":"N.J. Senff","year":"2007","unstructured":"Senff NJ, Willemze R. The applicability and prognostic value of the new TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sezary syndrome: results on a large cohort of primary cutaneous B-cell lymphomas and comparison with the system used by the Dutch Cutaneous Lymphoma Group. Br J Dermatol 2007; 157: 1205\u201311.","journal-title":"Br J Dermatol"},{"key":"3183_CR13","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1182\/blood.V99.3.800","volume":"99","author":"R. Fink-Puches","year":"2002","unstructured":"Fink-Puches R, Zenahlik P, B\u00e4ck B, Smolle J, Kerl H, Cerroni L. Primary cutaneous lymphomas: applicability of current classification schemes (European Organization for Research and Treatment of Cancer, World Health Organization) based on clinicopathologic features observed in a large group of patients. Blood 2002; 99: 800\u20135.","journal-title":"Blood"},{"key":"3183_CR14","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1016\/j.jaad.2012.02.033","volume":"67","author":"J.H. Park","year":"2012","unstructured":"Park JH, Shin HT, Lee DY, et al. World Health Organization-European Organization for Research and Treatment of Cancer classification of cutaneous lymphoma in Korea: a retrospective study at a single tertiary institution. J Am Acad Dermatol 2012; 67: 1200\u20139.","journal-title":"J Am Acad Dermatol"},{"key":"3183_CR15","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1038\/leu.2012.246","volume":"26","author":"A.W. Langerak","year":"2012","unstructured":"Langerak AW, Groenen PJ, Br\u00fcggemann M, et al. EuroClonality\/BIOMED-2 guidelines for interpretation and reporting of Ig\/TCR clonality testing in suspected lymphoproliferations. Leukemia 2012; 26: 2159\u201371.","journal-title":"Leukemia"},{"key":"3183_CR16","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1111\/cup.12047","volume":"40","author":"J.A. Plaza","year":"2013","unstructured":"Plaza JA, Feldman AL, Magro C. Cutaneous CD30-positive lymphoproliferative disorders with CD8 expression: a clinicopathologic study of 21 cases. J Cutan Pathol 2013; 40: 236\u201347.","journal-title":"J Cutan Pathol"},{"key":"3183_CR17","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1182\/blood-2006-10-054601","volume":"110","author":"Y.H. Kim","year":"2007","unstructured":"Kim YH, Willemze R, Pimpinelli N, et al. TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the Cutaneous Lymphoma Task Force of the European Organization of Research and Treatment of Cancer (EORTC). Blood 2007; 110: 479\u201384.","journal-title":"Blood"},{"key":"3183_CR18","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1177\/1536867X1201200408","volume":"12","author":"D. Consonni","year":"2012","unstructured":"Consonni D, Coviello E, Buzzoni C, Mensi C. The Stata Journal 2012; 12: 688\u2013701, http:\/\/www.stata-journal.com.","journal-title":"The Stata Journal"},{"key":"3183_CR19","first-page":"175","volume-title":"Statistical Methods in Medical Research","author":"P. Armitage","year":"1994","unstructured":"Armitage P, Berry G. The planning of statistical investigations. In: Statistical Methods in Medical Research. 4th ed. Armitage P, Berry G. Oxford: England Blackwell Scientific Publications, 1994: 175\u2013185."},{"key":"3183_CR20","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","volume":"127","author":"S.H. Swerdlow","year":"2016","unstructured":"Swerdlow SH, Campo E, Pileri SA, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 2016; 127: 2375\u201390.","journal-title":"Blood"},{"key":"3183_CR21","volume-title":"J Cutan Med Surg","author":"M. Maurelli","year":"2017","unstructured":"Maurelli M, Colato C, Gisondi P, Girolomoni G. Primary cutaneous CD4+ small\/medium pleomorphic T cell lymphoproliferative disorder: a case series. J Cutan Med Surg 2017. In press."},{"key":"3183_CR22","doi-asserted-by":"publisher","first-page":"4024","DOI":"10.1182\/blood-2011-05-351346","volume":"118","author":"W. Kempf","year":"2011","unstructured":"Kempf W, Pfaltz K, Vermeer MH, et al. EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma. Blood 2011; 118: 4024\u201335.","journal-title":"Blood"},{"key":"3183_CR23","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.ad.2009.07.019","volume":"101","author":"L. Calzado-Villarreal","year":"2010","unstructured":"Calzado-Villarreal L, Polo-Rodr\u00edguez I, Ortiz-Romero PL. Primary cutaneous CD30+ lymphoproliferative disorders. Actas Dermosifiliogr 2010; 101: 119\u201328.","journal-title":"Actas Dermosifiliogr"},{"key":"3183_CR24","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.1182\/blood.V95.12.3653","volume":"95","author":"M.W. Bekkenk","year":"2000","unstructured":"Bekkenk MW, Geelen FA, van Voorst Vader PC, et al. Primary and secondary cutaneous CD30+ lymphoproliferative disorders: a report from the Dutch Cutaneous Lymphoma Group on the long-term followup data of 219 patients and guidelines for diagnosis and treatment. Blood 2000; 95: 3653\u201361.","journal-title":"Blood"},{"key":"3183_CR25","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1111\/j.1365-2133.2010.10143.x","volume":"164","author":"D. Jenni","year":"2011","unstructured":"Jenni D, Karpova MB, Seifert B, et al. Primary cutaneous lymphoma: two-decade comparison in a population of 263 cases from a Swiss tertiary referral centre. Br J Dermatol 2011; 164: 1071\u20137.","journal-title":"Br J Dermatol"},{"key":"3183_CR26","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1111\/j.1365-2133.2006.07264.x","volume":"154","author":"J.D. Bouaziz","year":"2006","unstructured":"Bouaziz JD, Bastuji-Garin S, Poszepczynska-Guign\u00e9 E, Wechsler J, Bagot M. Relative frequency and survival of patients with primary cutaneous lymphomas: data from a single-centre study of 203 patients. Br J Dermatol 2006; 154: 1206\u20137.","journal-title":"Br J Dermatol"},{"key":"3183_CR27","doi-asserted-by":"publisher","first-page":"205e1","DOI":"10.1016\/j.jaad.2013.07.049","volume":"70","author":"S.I. Jawed","year":"2014","unstructured":"Jawed SI, Myskowski PL, Horwitz S, Moskowitz A, Querfeld C. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sezary syndrome) Part I. Diagnosis: Clinical and histopathologic features and new molecular and biologic markers. J Am Acad Dermatol 2014; 70: 205e1\u201316.","journal-title":"J Am Acad Dermatol"},{"key":"3183_CR28","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.jaad.2013.08.033","volume":"70","author":"S.I. Jawed","year":"2014","unstructured":"Jawed SI, Myskowski PL, Horwitz S, Moskowitz A, Querfeld C. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sezary syndrome) Part II. Prognosis, management, and future directions. J Am Acad Dermatol 2014; 70: 2e1-17.","journal-title":"J Am Acad Dermatol"},{"key":"3183_CR29","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/j.jaad.2005.08.057","volume":"53","author":"N. Pimpinelli","year":"2005","unstructured":"Pimpinelli N, Olsen EA, Santucci M, et al. Defining early mycosis fungoides. J Am Acad Dermatol 2005; 53: 1053\u201363.","journal-title":"J Am Acad Dermatol"},{"key":"3183_CR30","doi-asserted-by":"publisher","first-page":"e150","DOI":"10.1111\/jdv.13914","volume":"31","author":"D.E. Cieza-D\u00edaz","year":"2017","unstructured":"Cieza-D\u00edaz DE, Conde-Montero E, Menarguez-Palanca J, Longo-Imedio I. Epidemiological and clinical features of patients diagnosed with cutaneous T-cell lymphomas in a Spanish tertiary care hospital. J Eur Acad Dermatol Venereol 2017; 31: e150\u20133.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"3183_CR31","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1111\/bjd.14783","volume":"175","author":"P.L. Ortiz-Romero","year":"2016","unstructured":"Ortiz-Romero PL. Targeting KIR3DL2 in primary cutaneous anaplastic large cell lymphomas. Br J Dermatol 2016; 175: 246\u20137.","journal-title":"Br J Dermatol"},{"key":"3183_CR32","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.5858\/arpa.2014-0299-CC","volume":"138","author":"T.T. Lan","year":"2014","unstructured":"Lan TT, Brown NA, Hristov AC. Controversies and considerations in the diagnosis of primary cutaneous CD4+ small\/medium T-cell lymphoma. Arch Pathol Lab Med 2014; 138: 1307\u201318.","journal-title":"Arch Pathol Lab Med"},{"key":"3183_CR33","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1111\/j.1610-0387.2007.06337.x","volume":"5","author":"C. Assaf","year":"2007","unstructured":"Assaf C, Gellrich S, Steinhoff M, et al. Cutaneous lymphomas in Germany: an analysis of the Central Cutaneous Lymphoma Registry of the German Society of Dermatology (DDG). J Dtsch Dermatol Ges 2007; 5: 662\u20138.","journal-title":"J Dtsch Dermatol Ges"},{"key":"3183_CR34","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1200\/JCO.2006.09.6396","volume":"25","author":"N.J. Senff","year":"2007","unstructured":"Senff NJ, Hoefnagel JJ, Jansen PM, et al. Reclassification of 300 primary cutaneous B-Cell lymphomas according to the new WHO-EORTC classification for cutaneous lymphomas: comparison with previous classifications and identification of prognostic markers. J Clin Oncol 2007; 25: 1581\u20137.","journal-title":"J Clin Oncol"},{"key":"3183_CR35","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1590\/abd1806-4841.20153638","volume":"90","author":"M. Lima","year":"2015","unstructured":"Lima M. Cutaneous primary B-cell lymphomas: from diagnosis to treatment. An Bras Dermatol 2015; 90: 687\u2013706.","journal-title":"An Bras Dermatol"},{"key":"3183_CR36","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1038\/modpathol.2008.159","volume":"21","author":"H. Takino","year":"2008","unstructured":"Takino H, Li C, Hu S, et al. Primary cutaneous marginal zone B-cell lymphoma: a molecular and clinicopathological study of cases from Asia, Germany, and the United States. Mod Pathol 2008; 21: 1517\u201326.","journal-title":"Mod Pathol"},{"key":"3183_CR37","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1053\/j.semdp.2016.11.001","volume":"34","author":"L. Cerroni","year":"2017","unstructured":"Cerroni L. Past, present and future of cutaneous lymphomas. Semin Diagn Pathol 2017; 34: 3\u201314.","journal-title":"Semin Diagn Pathol"},{"key":"3183_CR38","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1046\/j.1440-1827.2000.01151.x","volume":"50","author":"Q. Liu","year":"2000","unstructured":"Liu Q, Ohshima K, Kikuchi M. Primary cutaneous B-cell lymphoma in Japanese patients. Pathol Int 2000; 50: 960\u20136.","journal-title":"Pathol Int"},{"key":"3183_CR39","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1002\/gcc.20513","volume":"47","author":"S. Hahtola","year":"2008","unstructured":"Hahtola S, Burghart E, Puputti M, et al. Cutaneous T-cell lymphoma associated lung cancers show chromosomal aberrations differing from primary lung cancer. Genes Chromosomes Cancer 2008; 47: 107\u201317.","journal-title":"Genes Chromosomes Cancer"},{"key":"3183_CR40","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/j.jaad.2016.06.011","volume":"75","author":"S.N. Tolkachjov","year":"2016","unstructured":"Tolkachjov SN, Weenig RH, Comfere NI. Cutaneous peripheral T-cell lymphoma, not otherwise specified: a single-center prognostic analysis. J Am Acad Dermatol 2016; 75: 992\u20139.","journal-title":"J Am Acad Dermatol"}],"container-title":["European Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1684\/ejd.2017.3183.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1684\/ejd.2017.3183\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1684\/ejd.2017.3183.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.jle.com\/10.1684\/ejd.2017.3183","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T16:21:59Z","timestamp":1741191719000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jle.com\/10.1684\/ejd.2017.3183"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,1]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1,1]]}},"alternative-id":["3183"],"URL":"https:\/\/doi.org\/10.1684\/ejd.2017.3183","relation":{},"ISSN":["1952-4013"],"issn-type":[{"type":"electronic","value":"1952-4013"}],"subject":[],"published":{"date-parts":[[2018,1,1]]},"assertion":[{"value":"2 Februar 2017","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2018","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}